CAS: 4085-31-8; 1,3-Bis(4-(7-Chloroquinolin-4-yl)Piperazin-1-yl)Propane

该化合物是一种长半衰期的碱性抗疟化合物,能够有效预防和治疗疟疾,特别是恶性疟原虫感染,由于它与 heme 紧密结合,抑制寄生虫的肝素形成,因此具有很高的威力;磷酸盐形式提高了溶性,提高了生物利用率,确保了药物动力学的一致性;磷酸经常用于混合疗法(例如,与二氢甲酸盐一起),以延缓抗药性发展,改善治疗结果;其广泛的治疗后预防效应降低了地方病地区的再感染风险;该化合物在标准储存条件下保持稳定,有利于热带气候的分布;临床研究支持其有效性,并有利于成人和儿科人群的耐受性.

结构式图片

上下游产品

CAS号109-64-8 1,3-二溴丙烷 | CAS号837-52-5 7-氯-4-(1-哌嗪基)喹啉 | CAS号86-98-6 4,7-二氯喹啉

合成工艺路线路线简述

    4,7-二氯喹啉置于三乙胺,Potassium Iodide体系中,用 甲醇,异丙醇 作为反应溶剂,化学反应 10.0H,反应生成 磷酸哌喹
    参考文献: An Improved Process For The Preparation Of Piperaquine[fr] Procédé Amélioré Pour La Préparation De Pipéraquine
    标题: An Improved Process For The Preparation Of Piperaquine[fr] Procédé Amélioré Pour La Préparation De Pipéraquine
    摘要:本发明涉及一种改进的制备7-氯-4-哌嗪-1-基喹啉(化学式(i))的过程,该化合物是合成哌喋啶或其药用可接受盐的关键中间体.

    海关参考信息

    专利信息


    专利号:US-9206133-B2
    优先权日:2011-06-06
    标题:Process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline
    发明人:CABRI WALTER; CASTAGNANI ROBERTO; ARMAROLI SILVIA; QUATTROCIOCCHI GIANANDREA; COLANGELI VINCENZO
    权利人:CABRI WALTER; CASTAGNANI ROBERTO; ARMAROLI SILVIA; QUATTROCIOCCHI GIANANDREA; COLANGELI VINCENZO; SIGMA TAU IND FARMACEUTI
    摘要:The present invention provides a new process of synthesis of a polymorph of 7-chloro-4-(piperazin-1-yl)-quinoline of Formula I. Said quinoline compound is substantially pure of any impurities. The present invention further provides the use of the above-mentioned polymorph of 7-chloro-4-(piperazin-1-yl)-quinoline in the synthesis of piperaquine or one of its pharmaceutically acceptable salts.

    专利号:US-2012100555-A1
    优先权日:2009-06-29
    标题 :Synthesis And Use Of Fluorophore-Tagged Antimalarials
    发明人:LEAR MARTIN JAMES; TAN KEVIN SHYONG WEI
    权利人:LEAR MARTIN JAMES; TAN KEVIN SHYONG WEI
    摘要:This invention includes a fluorophore-tagged antimalarial represented by the following structural formula (1) or a salt thereof. This invention relates to the synthesis of fluorophore-tagged antimalarials and describes the synthesis of a fluorophore-tagged antimalarial. These fluorophore-tagged antimalarials can be used to image live cells to determine the location of the antimalarial in the cell, identify drug resistance and growth related pathways in Plasmodium isolates, identify new drug targets and chemo-sensitizers to reverse drug resistance.

    专利号:US-9409879-B2
    优先权日:2011-03-29
    标 题 :Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents
    发明人:DAVIOUD-CHARVET ELISABETH; LANFRANCHI DON ANTOINE; JOHANN LAURE; WILLIAMS DAVID LEE; CESAR RODO ELENA
    权利人:DAVIOUD-CHARVET ELISABETH; LANFRANCHI DON ANTOINE; JOHANN LAURE; WILLIAMS DAVID LEE; CESAR RODO ELENA; CENTRE NAT RECH SCIENT
    摘要:Naphthoquinones, azanaphthoquinones and benxanthones, their process of synthesis and methods of their use as antimalarial or antischistosomal agents.

    专利号:US-9802952-B2
    优先权日:2013-07-15
    标 题:Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivatives
    发明人:KOPETZKI DANIEL; MCQUADE DAVID TYLER; SEEBERGER PETER H; GILMORE KERRY
    权利人:MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V; MAX-PLANK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V
    摘要:The present invention is directed to a method for continuous production of dihydroartemisinin and also artemisinin derivatives derived from dihydroartemisinin by using artemisinin or dihydroartemisinic acid (DHAA) as starting material as well as to a continuous flow reactor for producing dihydroartemisinin as well as the artemisinin derivatives. It was found that the reduction of artemisinin to dihydroartemisinin in a continuous process requires a special kind of reactor and a special combination of reagents comprising a hydride reducing agent, at least one activator such as an inorganic activator, at least one solid base, at least one aprotic solvent and at least one C 1 -C 5 alcohol.

    专利号:WO-2023187827-A1
    优先权日:2022-03-30
    标题:A pharmaceutical composition comprising an inhibitor of glutamine synthetase enzyme to combat artemisinin resistance in malaria
    发明人:ARUN NAGARAJ VISWANATHAN; PADMANABAN GOVINDARAJAN; GHOSH SOURAV; KUNDU RAJIB; CHANDANA MANJUNATHA; ANAND ADITYA
    权利人:INST OF LIFE SCIENCES
    摘要:The present disclosure relates to a pharmaceutical composition to combat artemisinin resistance in malaria with the identification of Plasmodium falciparum (Pf) glutamine synthetase (GS) as a drug target. Pf Gs is important for maintaining asparagine levels in the parasite and promote protein synthesis. Since ART-resistant parasites undergo fitness loss in amino acid/nutrient- limiting conditions and GS levels are upregulated during ART exposure, targeting Pf GS and asparagine requirement can be harnessed to prevent ART resistance. The present disclosure also provides a method of suppressing the growth of Plasmodium falciparum and a method of treating malaria using GS inhibitors.

    专利号:WO-2011095885-A1
    优先权日:2010-02-08
    标 题:An improved process for the preparation of piperaquine
    发明人:SETHI MADHURESH KUMAR; RAWAT VIJENDRA SINGH; AYYARAN KARTHIKEYAN; YERRAMALLA RAJA KRISHNA; BONTALAKOTI JAGAN MOHAN RAO; VEMULA LAKSHMINARAYANA; NIMMAGADDA ANITHA; DATTA DEBASHISH
    权利人:MATRIX LAB LTD; SETHI MADHURESH KUMAR; RAWAT VIJENDRA SINGH; AYYARAN KARTHIKEYAN; YERRAMALLA RAJA KRISHNA; BONTALAKOTI JAGAN MOHAN RAO; VEMULA LAKSHMINARAYANA; NIMMAGADDA ANITHA; DATTA DEBASHISH
    摘要:The present invention relates to an improved process for the preparation of 7-chloro- 4-piperazin-1-yl-quinoline of formula (I), a key intermediate for the synthesis of Piperaquine or its pharmaceutically acceptable salts.
    珠海润都制药股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.rdpharma.cn
    电话: 0756-7630356👤
    📞珠海润都制药股份有限公司 ⚠️参考联系方式

    销售电话:0756-7630356
    邮箱:sales@rdpharma.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    诺圣华化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.rosewachem.com
    电话: 86-023-62871537 023-62833877 18983840262👤
    📞诺圣华化工有限公司 ⚠️参考联系方式

    销售电话:86-023-62871537 023-62833877 18983840262
    邮箱:sales@rosewachem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Ba Konko Ciré EH, Roh ME, Diallo A, Gadiaga T, Seck A, Thiam S, Gaye S, Diallo I, Lo AC, Diouf E, Ba OG, Gueye AB, Fogelson A, Wu X, Milligan P, Kibuka T, Hama M, Eckert E, Thwing J, Bennett A, Gosling R, Hwang J, Sene D, Ba F, Cissé B, Sturm-Ramirez K, Hsiang MS, Ndiaye JL. Mass drug administration to reduce malaria incidence in a low-to-moderate endemic setting: short-term impact results from a cluster randomised controlled trial in Senegal. medRxiv [Preprint]. 2024 Jul
    18:2024.07.17.24310593. doi: 10.1101/2024.07.17.24310593.
    2: Rosado J, Fola AA, Cojean S, Sarrasin V, Coppée R, Zaffaroulah R, Bouzayene A, Cicéron L, Houzé L, Crudale R, Musset L, Thellier M, Pradines B, Clain J, Bailey JA, Houzé S; Investigation Study Group. Ex vivo susceptibility to antimalarial drugs and polymorphisms in drug resistance genes of African Plasmodium falciparum, 2016-2023: a genotype-phenotype association study. medRxiv [Preprint]. 2024 Jul

    合成参考文献


    参考文献:10.1186/1475-2875-10-185|10.1186/1475-2875-10-198
    摘要:Menan H, Faye O, Same-Ekobo A, Oga ASS, Faye B, Kiki Barro CP, Kuete T, N'diaye J, Vicky A, Tine R, Yavo W, Kane D, Kassi KF, Kone M. Comparative study of the efficacy and tolerability of dihydroartemisinin - piperaquine - trimethoprim versus artemether - lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal. Malaria Journal. 2011 Jul 08;10(1):185. doi: 10.1186/1475-2875-10-185.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知